Impact BioMedical, Inc. is a holding company, which engages in the discovery and development of products and treatment options in specialty biopharmaceuticals and consumer healthcare. The firm focuses on the advancement of drug discovery and prevention, inhibition, and treatment of neurological, oncological, and immune related diseases. It is also involved in developing open-air defense initiatives, which curb transmission of air-borne infectious diseases, such as tuberculosis and influenza. The company was founded on October 16, 2018 and is headquartered in Houston, TX.
Sector:
Electronic Technology
Industry:
Electronic Equipment Or Instruments
Employees:
2
Frequently Asked Questions
What is Market Cap of Impact BioMedical Inc.?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Impact BioMedical Inc. market cap is $8.02M.
What is the 52-week high for Impact BioMedical Inc.?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Impact BioMedical Inc. 52 week high is $6.17 as of September 28, 2025.
What is the 52-week low for Impact BioMedical Inc.?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Impact BioMedical Inc. 52 week low is $0.3621 as of September 28, 2025.
What is Impact BioMedical Inc. stock price today?
Impact BioMedical Inc. stock price today is $0.6578.
What was Impact BioMedical Inc. stock price yesterday?
Impact BioMedical Inc. stock price yesterday was $0.6479.
What is the PE ratio of Impact BioMedical Inc.?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Impact BioMedical Inc.’s P/E ratio is -0.20.
What is the Price-to-Book ratio of Impact BioMedical Inc.?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Impact BioMedical Inc. P/B ratio is -0.7707.
What is the 50-day moving average of Impact BioMedical Inc.?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Impact BioMedical Inc. 50-day moving average is $0.6283.
How many employess does Impact BioMedical Inc. has?
